首页> 外文期刊>Journal of thrombosis and haemostasis: JTH >Classification of rare bleeding disorders (RBDs) based on the association between coagulant factor activity and clinical bleeding severity
【24h】

Classification of rare bleeding disorders (RBDs) based on the association between coagulant factor activity and clinical bleeding severity

机译:基于凝血因子活性与临床出血严重程度之间的关联对罕见出血性疾病(RBD)进行分类

获取原文
获取原文并翻译 | 示例
           

摘要

Rare bleeding disorders (RBDs) include the inherited deficiencies of coagulation factors, fibrinogen, factor (F)II, FV, FV + FVIII, FVII, FX, FXI and FXIII, and are usually transmitted as autosomal recessive disorders [1]. Due to their rarity, they sometimes present significant challenges in diagnosis and treatment [2]. The development of guidelines for classification and treatment of these disorders has been hampered by a lack of sufficient knowledge about epidemiology and clinical outcomes, the difficulty in recognizing affected patients and coEecting longitudinal clinical data, the limits of laboratory assays, and a lack of consensus concerning the criteria by which these disorders are classified. A collaboration among experts on RBDs was therefore proposed.
机译:稀有出血性疾病(RBD)包括遗传性凝血因子,纤维蛋白原,因子(F)II,FV,FV + FVIII,FVII,FX,FXI和FXIII的遗传缺陷,通常以常染色体隐性遗传疾病的形式传播[1]。由于它们的稀有性,它们有时在诊断和治疗方面提出重大挑战[2]。由于缺乏对流行病学和临床结局的充分了解,难以识别受影响的患者和收集纵向临床数据,实验室检测的局限性以及缺乏关于这些疾病的共识,阻碍了这些疾病的分类和治疗指南的制定。这些疾病的分类标准。因此,提出了关于RBD的专家之间的合作。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号